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Background
The gp120 CD4 binding site (CD4bs) and coreceptor
binding site (CoRbs) are two functionally conserved ele-
ments of the HIV-1 envelope glycoproteins (Env). We pre-
viously defined the presence of CD4bs neutralizing
antibodies (nAbs) in the serum of an HIV-1 infected indi-
vidual and subsequently isolated the CD4bs-specific
monoclonal antibodies (mAbs) VRC01 and VRC03 from
the memory B cell population. From the same patient
sera, we detected that there was also a fraction of potent
nAbs specific for elements of the Env CoRbs by differential
protein adsorption followed by neutralization analysis.
Methods
In this study, we employed a differential FACS-based sort-
ing strategy using a stabilized gp120 core and a mutant
gp140 possessing a CoRbs “knockout” mutation (I420R) to
isolate CoRbs specific B cells.
Results
The mAb VRC06 was recovered from these cells and its
genetic sequence allowed us to identify a clonal relative,
VRC06b, which had been isolated from a prior cell sort
using a resurfaced core gp120 probe. VRC06 and
VRC06b neutralized 22% and 44% of circulating viruses
tested, respectively. Virus neutralization assays revealed
that VRC06/VRC06b better neutralized autologous
viruses compared to VRC01 and VRC03. More potent
autologous neutralization was associated with a 7 amino
acid residues insertion in the framework of the VH gene-
coding region. Epitope mapping studies demonstrated
that the two mAbs were sensitive to mutations in both
the gp120 CD4bs and the CoRbs, including the gp120
bridging sheet and the base of the third major variable
region (V3). Interestingly, cell-surface binding assays
demonstrated their preferential recognition of fully-
cleaved Env trimers compared to un-cleaved trimers.
Conclusion
VRC06 and VRC06b are novel neutralizing mAbs that
bind to a region of gp120 that overlaps with both the pri-
mary and secondary HIV-1 receptor binding sites, prefer-
entially recognize fully-cleaved Env, and complement the
neutralizing capacity of other CD4bs bNAbs isolated from
the same individual.
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